EVA KHAVKIN: Open Payments
NPI 1306884978 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$656 in 7 payments from 4 companies in 2025. Trend: 2023 $900 · 2024 $408 · 2025 $656
Food & beverage: $656
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 2 | $245 |
| E.R. Squibb & Sons, L.L.C. | 2 | $146 |
| Vanda Pharmaceuticals Inc. | 2 | $140 |
| Alkermes, Inc. | 1 | $125 |
Products named: REXULTI, COBENFY, FANAPT, LYBALVI.
Industry payments across NY — which companies pay providers there.
